U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038837) titled 'Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad' on June 03.
Brief Summary: This is a two-arm, cluster-randomised, phase IV trial conducted in Chad to assess the protective efficacy and impact in real-life conditions of a new strategy for administering the R21/MM malaria vaccine, synchronized within a seasonal malaria chemoprevention (SMC) campaign, among children living in areas of high seasonal malaria transmission.
In this study, a cluster is defined as the catchment area of a primary care health centre. In Chad, each catchment area is known as a 'zone...